Patents
Invention: „Micro-organism strain Pediococcus acidilactici TAK 589 Coccobest as an antimicrobial and antioxidative probiotic“
Pending patent applications:
International Patent Application PCT/EE2021/000003, filed 17.09.2021: „Micro-organism strain Pediococcus acidilactici TAK 589 Coccobest as an antimicrobial and antioxidative probiotic“
Leiutis: “Microorganism strain Lactobacillus buchneri BioCC 228 DSM 32651 and use thereof”
Patents:
Estonian patent EE05834B1, issued 17.05.2021
The invention provides the isolated microorganism strain Lactobacillus buchneri BioCC 228 DSM 32651 and its use as microbiological feed additive. The strain is used for ensuring aerobic stability of feed with low dry matter content ( 20 percentage) and improving fermentation of feed, for increasing the concentration of lactic and acetic acid in feed and for reducing pH, hence decreasing the loss of nutrients in feed. Usage of the microorganism in ensiling supresses the function of pathogenic microorganisms (enteropathogens) and yeasts in feed.
Invention: “Isolated microorganism strain Lactobacillus plantarum TENSIA® DSM 21380 as antimicrobial and antihypertensive probiotic, food product and composition comprising said microorganism and use of said microorganism for preparation of antihypertensive medicine and method for suppressing pathogens and nonstarter lactobacilli in food product”
Patents:
- Estonian patent EE05340, granted 16.08.2010, “Isolated microorganism strain Lactobacillus plantarumTensia DSM 21380 as antimicrobial and antihypertensive probiotic, food product and composition comprising said microorganism and use of said microorganism for preparation of antihypertensive medicine and method for suppressing pathogens and nonstarter lactobacilli in food product”.
- Russian patent RU2477750, granted 20.03.2013, “Изолированный штамм микроорганизма Lactobacillus plantarum Tensia DSM 21380 как противомикробный и гипотензивный пробиотик, продукт питания и композиция, содержащая упомянутый микроорганизм, и применение упомянутого микроорганизма для получения гипотензивного лекарственного средства, способ подавления патогенов и побочных лактобактерий в продукте питания“.
- European patent EP2309870, granted 04.05.2012, “Isolated microorganism strain Lactobacillus plantarum Tensia DSM 21380 as antimicrobial and antihypertensive probiotic, food product and composition comprising said microorganism and use of said microorganism for preparation of antihypertensive medicine and method for suppressing pathogens and non-starter lactobacilli in food product”.
EP2309870 is validated in:
- United Kingdom GP/EP2309870
- Sweden SE/EP2309870
- Germany DE/EP2309870 (60 2009 007 496.2)
- France FR/EP2309870
- Finland FI/EP2309870
- Czech CZ/EP2309870
- Poland PL/EP2309870
- Hungary HU/EP2309870
- Lithuania LT/EP2309870
- Latvia LV/EP2309870
- Korean patent KR10-1587195, granted 14.01.2016, 항균 및 항고혈압 프로바이오틱인 단리된 미생물 균주 락토바실러스 플란타룸 텐시아 ＤＳＭ 21380과, 이 미생물을 포함하는 식품과 조성물 및 항고혈압제의 제조를 위한 이 미생물의 용도와, 식품에서 병원체 및 논-스타터 락토바실러스를 억제하기 위한 방법 („Isolated microorganism strain Lactobacillus plantarum Tensia DSM 21380 as antimicrobial and antihypertensive probiotic, food product and composition comprising said microorganism and use of said microorganism for preparation of antihypertensive medicine and method for suppressing pathogens and non-starter lactobacilli in food product“).
Invention: “Isolated Lactobacillus plantarum strain INDUCIA® DSM 21379 as probiotic that enhances natural immunity and food products and medicinal preparations comprising it”.
Patents:
- Estonian patent EE05341, granted 16.08.2010, “Isolated Lactobacillus plantarum strain INDUCIA® DSM 21379 as probiotic that enhances natural immunity and food products and medicinal preparations comprising it”.
- Russian patent RU2486234, granted 27.06.2013, “Изолированный штамм микроорганизма Lactobacillus Plantarum Inducia DSM 21379 в качестве пробиотика, усиливающего врожденный иммунитет организма, продукт и композиция, содержащие упомянутый микроорганизм, и применение упомянутого микроорганизма для изготовления лекарственного средства, которое усиливает клеточный иммунитет”.
- European patent EP2288360, granted 14.12.2011, “Isolated Lactobacillus plantarum strain Inducia DSM 21379 as probiotic that enhances natural immunity and food products and medicinal preparations comprising it”.
EP2288360 is validated in:
- United Kingdom GB/EP2288360
- Sweden SE/EP2288360
- Germany DE/EP2288360 (60 2009 004 223.8)
- France FR/EP2288360
- Finland FI/EP2288360
- Denmark DK/EP2288360
- Poland PL/EP2288360
- Lithuania LT/EP2288360
- Latvia LV/EP2288360
- Korean patent KR10-1595042, granted 11.02.2016, “자연 면역을 증가시키는 프로바이오틱인 단리된 락토바실러스 플란타룸 균주 인듀시아 ＤＳＭ 21379와, 이를 포함하는 식품과 의약적 제제 (“Isolated Lactobacillus plantarum strain Inducia DSM 21379 as probiotic that enhances natural immunity and food products and medicinal preparations comprising it”).
Invention: “Composition comprising hypocholesterolemic probiotic microorganism strain Lactobacillus plantarum Inducia DSM 21379 for use in preventing cardiovascular disorders”
Estonian Patent EE05799, granted 16.10.2017, “Composition comprising hypocholesterolemic probiotic microorganism strain Lactobacillus plantarum Inducia DSM 21379 for use in preventing cardiovascular disorders”
Invention „Lactobacillus plantarum INDUCIA® strain DSM 21379 as hypocholesterolemic agent and antimicrobial agent against Clostridium Difficile”
Estonian patent EE 05809 B1, granted 17.09.2018, Composition containing probiotic microorganism strain Lactobacillus plantarum Inducia DSM21379 which can be used as an antimicrobial
agent in lowering the risk of Clostridium difficile associated diarrhoea (CDAD).
USA patent US10272122, granted 30.04.2019, “Lactobacillus plantarum Inducia DSM 21379 as enhancer of cellular immunity, hypocholesterolemic and anti-oxidative agent and antimicrobial agent against Clostridium difficile”.
Pending patent applications:
- International Patent Application PCT/EE2014000007, filed 31.10.2014 “Lactobacillus plantarum INDUCIA strain DSM 21379 as hypocholesterolemic agent and antimicrobial agent against Clostridium Difficile”
Invention: “Isolated microorganism strains Lactobacillus plantarum MCC1 DSM 23881 and Lactobacillus gasseri MCC2 23882 and their use”
Patents:
- Estonian patent EE05721, granted 15.08.2014, „Isolated microorganism strain plantarum MCC1 DSM 23881 and its use”
- Estonian patent EE05750, granted 15.06.2015, “Isolated microorganism strain Lactobacillus gasseri MCC2 DSM 23882 and its use”
- European patent EP2678419, granted 23.09.2015, “Isolated microorganism strain Lactobacillus plantarum MCC1 DSM 23881 and its use”. EP2678419 is validated in:
- Ireland IE/EP2678419
- Germany DE/ EP2678419
- France FR/ EP2678419
- Finland FI/ EP2678419
- Serbia RS/ EP2678419
- Switzerland CH/ EP2678419
- Lithuania LT/ EP2678419
- Latvia LV/ EP2678419
- United Kingdom GB/ EP2678419
- European patent EP2966164, granted 19.04.2017, “Isolated microorganism strain Lactobacillus gasseri MCC2 DSM 23882 and its use”.
EP2966164 is validated in:
- Ireland IE/EP2966164
- Germany DE/EP2966164
- France FR/EP2966164
- Switzerland CH/EP2966164
- United Kingdom GB/EP2966164
- Korean Patent KR10-1586778, granted 13.01.2016, “분리된 미생물 균주 락토바실러스 플란타룸 MCC1 DSM 23881 및 락토바실러스 가서리” MCC2 DSM 23882와 그의 용도 („Isolated microorganism strains Lactobacillus plantarum MCC1 DSM 23881 and Lactobacillus gasseri MCC2 DSM 23882 and their use)”.
- Chinese patent CN1996956, granted 23.03.2016, “Isolated microorganism strains Lactobacillus plantarumMCC1 DSM 23881 and Lactobacillus gasseri MCC2 23882 and their use”.
- Japan Patent JP5785275, granted 31.07.2015, “Isolated microorganism strains Lactobacillus plantarum MCC1 DSM 23881 and Lactobacillus gasseri MCC2 23882 and their use”.
- Russian Patent RU2603059, granted 20.11.2016, “Изолированные штаммы микроорганизмов Lactobacillus plantarum MCC1 DSM 23881 и Lactobacillus gasseri MCC2 DSM 23882 и их применение” (“Isolated microorganism strains Lactobacillus plantarum MCC1 DSM 23881 and Lactobacillus gasseri MCC2 23882 and their use”).
Pending Patent Applications:
- Chinese Patent Application CN201610114800.5, filed 13.07.2016 “Isolated microorganism strain Lactobacillus gasseri MCC2 23882 and its use”.
Invention: “Microorganism Lactobacillus plantarum TAK 59 NCIMB42150 and its use”
Patents:
- Estonian patent EE05746, granted 15.05.2015, ”Microorganism Lactobacillus plantarum TAK 59 NCIMB42150 and use thereof”.
- European patent EP3027734, granted 25.10.2017, “Isolated microorganism strain Lactobacillus plantarum TAK 59 NCIMB42150 and its use.
- Japanese patent JP6514201, granted 19.04.2019, “Microorganism Lactobacillus plantarum TAK 59 NCIMB42150 and its use”.
Pending Patent Applications:
- Russian patent application RU2016107018,filed 26.02.2016 “Изолированный штамм микроорганизма Lactobacillus plantarum TAK 59 NCIMB42150 и его применение”.
- International patent application PCT/EE2014/000003, filed 30.07.2014, “Microorganism Lactobacillus plantarum TAK 59 NCIMB42150 and its use”.
Invention: “Microorganism Lactobacillus brevis TAK 124-1 NCIMB42149 and its use”
Patents:
- Estonian patent EE05756,granted 16.11.2015, “Isolated microorganism strain Lactobacillus brevis TAK 124-1 NCIMB42149 and use thereof”.
Pending Patent Applications:
- International patent application PCT/EE2015/000001,filed 13.02.2015, “Microorganism Lactobacillus brevis TAK 124-1 NCIMB42149 and its use”.
Invention: “A method for identifying of cows, sires and bull dams that produce milk with modified coagulation properties”
- Estonian patent EE05659, granted 17.06.2013, “Method of identifying of cows, sires and bull dams producing milk with modified coagulation properties”.
- Russian patent RU2409942, granted 27.01.2011, “Способ идентификации крупного рогатого скота, производящего молоко с модифицированными коагуляционными свойствами”.
- European patent EP2053914, granted 26.01.2011,“Method of identifying of cows, sires and bull dams producing milk with modified coagulation properties”.